What is it about?
Dantrolene, originally developed to treat malignant hyperthermia was given to a patient with rhabdomyolysis resulting from bacterial toxins
Featured Image
Why is it important?
Dantrolene may interrupt states of rhabdomyolisis, independant from its origin
Perspectives
to increase application spectrum of dantrolene in times of increasing rhabdomyolysis states ( drugs, bacterials, environment conditions as heat stroke, etc...)
Hans F Ginz
Universitat Basel
Read the Original
This page is a summary of: Dantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome, European Journal of Anaesthesiology, March 2012, Wolters Kluwer Health,
DOI: 10.1097/eja.0b013e32834c7c9d.
You can read the full text:
Contributors
The following have contributed to this page
